Role of Endoscopic Ultrasound in Gastroenteropancreatic Neuroendocrine Tumors and Update on Their Treatment
Deepak Kumar Bhasin
Citation Information :
Bhasin DK. Role of Endoscopic Ultrasound in Gastroenteropancreatic Neuroendocrine Tumors and Update on Their Treatment. J Postgrad Med Edu Res 2013; 47 (1):54-60.
Rana SS, Sharma V, Bhasin DK. Role of Endoscopic Ultrasound in Gastroenteropancreatic Neuroendocrine Tumors and Update on Their Treatment. J Postgrad Med Edu Res 2013;47(1):54-60.
Updated population-based review of carcinoid tumors. Ann Surg 2004;240:117-22.
One hundred years after ‘carcinoid’: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26:3063-72.
Endoscopic ultrasound in gastroenteropancreatic neuroendocrine tumors. Gut Liver 2012;6:405-10.
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 2012;61:6-32.
Preoperative detection of gastrointestinal neuroendocrine tumors using endoscopic ultrasonography. Rev Esp Enferm Dig 2006;98:828-36.
The role of endoscopic ultrasonography in the diagnosis and management of pancreatic cancer. Gastroenterol Clin North Am 2012;41:179-88.
Levels of evidence in endoscopic ultrasonography: A systematic review. Dig Dis Sci 2012;57:602-09.
EUS for pancreatic neuroendocrine tumors: A single-center, 11-year experience. Gastrointest Endosc 2010;71:1185-93.
Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography and angiography. Gastroenterology 1992;102:188-99.
Localization of islet cell tumors by endoscopic ultrasonography. Gastroenterology 1992;103:711-12.
Pancreatic tumors: Evaluation with endoscopic US, CT, and MR imaging. Radiology 1994;190:745-51.
Ga-68 DOTATOC PET, endoscopic ultrasonography, and multidetector CT in the diagnosis of duodenopancreatic neuroendocrine tumors: A single-centre retrospective study. Clin Nucl Med 2010;35:321-28.
Endosonography in decision making and management of gastrointestinal endocrine tumors. Eur J Ultrasound 1999;10:139-50.
EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasia. Gastrointest Endosc 2003;58:531-35.
Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. Ultrasound Med Biol 2008;34:525-32.
Usefulness of EUS combined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc 2010;71:951-59.
Endoscopic ultrasonography (EUS) in the localization of insulinoma. Endocrine 2007;31:238-41.
Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: A study of 48 cases. Cancer 2008;114:255-62.
The role of cytomorphology and proliferative activity in predicting biologic behavior of pancreatic neuroendocrine tumors: A study by endoscopic ultrasound-guided fine-needle aspiration cytology. Cancer 2009;117:211-16.
Carcinoid tumors of the gastrointestinal tract: Evaluation with endoscopic ultrasonography. Gastrointest Endosc 1993;39:375-83.
Indications of endoscopic polypectomy for rectal carcinoid tumors and clinical usefulness of endoscopic ultrasonography. Dis Colon Rectum 2005;48:285-91.
Endoscopic ultrasound-assisted endoscopic resection of carcinoid tumors of the gastrointestinal tract. Rev Esp Enferm Dig 2004;96:847-55.
Usefulness of endoscopic submucosal dissection for the treatment of rectal carcinoid tumors. Eur J Gastroenterol Hepatol 2012;24:770-74.
Endoscopic submucosal dissection for rectal carcinoid tumors. Surg Endosc 2010;24:504-08.
Review of the pathogenesis, diagnosis, and management of type I gastric carcinoid tumor. World J Surg 2011;35:1879-86.
Gastric carcinoids: Between underestimation and overtreatment. World J Gastroenterol 2009;15:2177-83.
Radio-frequency ablation for symptom control in a patient with metastatic pancreatic insulinoma. Clin Endocrinol (Oxf) 2002;56:557-59.
EUS-guided alcohol ablation of an insulinoma. Gastrointest Endosc 2006;63:1059-62.
Endoscopic ultrasound-guided ethanol ablation of a symptomatic sporadic insulinoma. Endoscopy 2011;43(Suppl 2)UCTN:E328-29.
Successful endoscopic ultrasound-guided ethanol ablation of a sporadic insulinoma. Acta Gastroenterol Belg 2008;71:333-37.
Treatment of a pancreatic endocrine tumor by ethanol injection (PEI) guided by endoscopic ultrasound. Endoscopy 2008 Sep;40(Suppl 2):E83.
US-guided ethanol ablation of insulinomas: A new treatment option. Gastrointest Endosc 2012;75:200-06.
Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook. Ann Oncol 1999;10(Suppl 2):S31-38.
Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: A prospective study in 39 patients. Gut 1996;39:279-83.
Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol 2001;12(Suppl 2):S111-14.
Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours. Eur J Cancer 1992;28A:1647-50.
Combination therapy with octreotide and alphainterferon: Effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors. Am J Gastroenterol 1999; 94:1381-87.
Eastern Cooperative Oncology G. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281. J Clin Oncol 2005;23:4897-904.
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer 1999; 81:1351-55.
Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma. Best Pract Res Clin Endocrinol Metab 2007;21:163-72.
Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 2011;364: 514-23.
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 2011;364:501-13.
Targeting vascular endothelial growth factor in advanced carcinoid tumor: A random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. J Clin Oncol 2008;26:1316-23.
Neuroendocrine tumors. Peptide receptor radionuclide therapy. Best Pract Res Clin Endocrinol Metab 2007;21:111-29.
Treatment of neuroendocrine tumor liver metastases. Int J Hepatol 2012:973-946.
Liver transplantation for metastatic neuroendocrine carcinoma: An analysis of 103 patients. Transplantation 1998;66: 1307-12.